Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Sagimet Biosciences Inc
SGMT
Healthcare
Biotechnology
Sagimet Biosciences Inc. is a clinical-stage biopharmaceutical company developing fatty acid synthase (FASN) inhibitors that are designed to target dysfunctional metabolic and fibrotic pathways in diseases resulting from the overproduction of the fatty acid, palmitate. The Company's lead drug candidate, denifanstat, is an oral, once-daily pill and selective FASN inhibitor in development for the...
treatment of metabolic dysfunction associated steatohepatitis (MASH). Denifanstat has been granted Breakthrough Therapy designation by the FDA for the treatment of non-cirrhotic MASH with moderate to advanced liver fibrosis. The Company is also exploring the use of its FASN inhibitors, which include denifanstat and its pipeline product candidate, TVB-3567, in acne and in select forms of cancer. Denifanstat is being tested in China by its license partner, Ascletis BioScience Co. Ltd., for moderate to severe acne vulgaris and recurrent glioblastoma multiforme in combination with bevacizumab.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:SGMT)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
Next
(215)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Dec 17, 2024 1:35pm
Sold my shares today
For a profit of one dollar per share,so that's alright for me.It was starting to churn over and over again.Good luck to all of you guys out there who are staying with this stock.
(215)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Dec 16, 2024 10:59am
Using technical analysis for this one.
Got some shares this morning at $5.15 cents per share and it is for day purposes only,so good luck to all.
(0)
•••
PressRelease
X
Post by
PressRelease
on Jan 25, 2024 8:58pm
New Press Release - Sagimet Biosciences Announces Pricing of Public Offering of Series A Common Stock
SAN MATEO, Calif., Jan. 25, 2024 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (“Sagimet”) (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel fatty acid synthase (FASN) inhibitors designed to target dysfunctional metabolic and fibrotic pathways, today announced the pricing...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Jan 23, 2024 5:46pm
New Press Release - Sagimet Biosciences Announces Proposed Public Offering of Series A Common Stock
SAN MATEO, Calif., Jan. 23, 2024 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (“Sagimet”) (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel fatty acid synthase (FASN) inhibitors designed to target dysfunctional metabolic and fibrotic pathways, today announced the...
read article.
(103)
•••
Iseneschal
X
Post by
Iseneschal
on Jan 22, 2024 1:32pm
SGMT..... Scalped
Cheers !!!!
(103)
•••
Iseneschal
X
Post by
Iseneschal
on Jan 22, 2024 12:12pm
SGMT....$13.69 crucial support now
It better pick up and vols increase
(103)
•••
Iseneschal
X
Comment by
Iseneschal
on Jan 22, 2024 12:09pm
RE:SGMT....has to rip over $16 for me to buy
Possible tank...now sub 14
(103)
•••
Iseneschal
X
Post by
Iseneschal
on Jan 22, 2024 12:01pm
SGMT....draw a line from ~ $6 to where its at now
Thats called a RBL Better stay above or its all over
(103)
•••
Iseneschal
X
Post by
Iseneschal
on Jan 22, 2024 11:58am
SGMT....has to rip over $16 for me to buy
I see this tanking
(103)
•••
Iseneschal
X
Post by
Iseneschal
on Jan 22, 2024 11:50am
SGMT....and now for the "Ugly"
Waiting for the gap south?
(103)
•••
Iseneschal
X
Post by
Iseneschal
on Jan 22, 2024 11:37am
SGMT...hurry up and Kick the bucket ; )
Buh Bye
(103)
•••
Iseneschal
X
Post by
Iseneschal
on Jan 22, 2024 11:24am
SGMT.....and now for the "sideways action"
til it isn't Range..... $12.20 to $13.50
(103)
•••
Iseneschal
X
Post by
Iseneschal
on Jan 22, 2024 11:17am
SGMT....30 mins of bliss...then the infamous "rug pull"
Now at N.L.O.D $12.22 What f'king game You've all been had ....again !
(103)
•••
Iseneschal
X
Post by
Iseneschal
on Jan 22, 2024 11:00am
SGMT...vols are increasing slightly but....
they are all down volume Place ur bets
(103)
•••
Iseneschal
X
Post by
Iseneschal
on Jan 22, 2024 10:57am
SGMT......Imploding....now at $13.....
With a N.L.O.D of $12.50 Saved all ur a$$e$ again
Prev
1
2
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Largest integrated facility services provider in Canada releases financial results for Q1, 2025
How Web3 Will Fundamentally Reshape Finance
This company is set to benefit from a change in Ontario legislation